Publications by authors named "Xiao-Dong Jiao"

Claim this Profile
T
Targeted therapy in advanced -mutated colorectal cancer: systematic review and network meta-analysis.
Bao-Dong Qin, Xiao-Dong Jiao, Zhan Wang, Ke Liu, Yan Ling

BMJ· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.
Zhan Wang, Bao-Dong Qin, Chen-Yang Ye, Miao-Miao Wang, Ling-Yan Yuan, Xiao-Dong Jiao

Signal Transduct Target Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Molecular Tumor Board on Clinical Outcomes in Patients with Refractory Solid Tumor: a Real-World Study.
Yan Ling, Xiao-Dong Jiao, Bao-Dong Qin, Jiang-Shui Ding, Zhan Wang

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer.
Jia-Jun Hui, Han-Lu Yan, Sheng-Jun Ding, Bao-Dong Qin, Xiao-Dong Jiao

Cancer Control· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial.
Ke Liu, Bao-Dong Qin, Shi-Qi Chen, Xue Zhong, Xiao-Peng Duan, Xiao-Dong Jiao

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation.
Si-Jia Sun, Xiao-Dong Jiao, Zhi-Gang Chen, Qi Cao, Jia-Hui Zhu

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy.
Bao-Dong Qin, Xiao-Dong Jiao, Ling-Yan Yuan, Ying Wu, Yan Ling

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New clinical trial design in precision medicine: discovery, development and direction.
Xiao-Peng Duan, Bao-Dong Qin, Xiao-Dong Jiao, Ke Liu, Zhan Wang

Signal Transduct Target Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M.
Liang-Sheng Wang, Shi-Qi Chen, Xue Zhong, Xiao-Dong Jiao, Ke Liu

Anticancer Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.
Bao-Dong Qin, Xiao-Dong Jiao, Zhan Wang, Ke Liu, Ying Wu

Int J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, Ke Liu, Ying Wu

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy.
Xiao-Peng Duan, Ke Liu, Xiao-Dong Jiao, Bao-Dong Qin, Bing Li

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8T cells.
Biaolong Yang, Biaolong Deng, Xiao-Dong Jiao, Bao-Dong Qin, Yi Lu

Cell Oncol (Dordr)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC.
Bao-Dong Qin, Xiao-Dong Jiao, Yan Wang, Ying Wu, Yan Ling

Lung Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report.
Xi He, Xiao-Dong Jiao, Ke Liu, Bao-Dong Qin, Ying Wu

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial.
Zhan Wang, Bao-Dong Qin, Chen-Yang Ye, Miao-Miao Wang, Ling-Yan Yuan, Xiao-Dong Jiao

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer.
Bao-Dong Qin, Xiao-Dong Jiao, Xin-Cheng Zhou, Bin Shi, Jian Wang

Oncoimmunology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma.
Xiao-Dong Jiao, Ke Liu, Ying Wu, Xin-Cheng Zhou, Bao-Dong Qin

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma.
Xiao-Dong Jiao, Li-Ren Ding, Chuan-Tao Zhang, Bao-Dong Qin, Ke Liu

Transl Lung Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.
Xiao-Dong Jiao, Ke Liu, Mingyan Xu, Guanzhen Yu, Danni Liu

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary squamous cell carcinoma of pancreas: a population-based study.
Wen-Xing Qin, Ying Wu, Jun Liu, Bao-Dong Qin, Ke Liu, Xiao-Dong Jiao

Gland Surg· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types.
Xiao-Dong Jiao, Xiao-Chun Zhang, Bao-Dong Qin, Dong Liu, Liang Liu, Jian-Jiao Ni

Ann Transl Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report.
Jin-Ju Guo, Xiao-Dong Jiao, Ying Wu, Bao-Dong Qin, Ke Liu

Onco Targets Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer.
Bao-Dong Qin, Xiao-Dong Jiao, Jun Liu, Ke Liu, Xi He

Crit Rev Oncol Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of tumor mutation burden in -mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base.
Xiao-Dong Jiao, Xi He, Bao-Dong Qin, Ke Liu, Ying Wu

J Thorac Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis